Alzheimer’s Research Papers~ May 2002 ~ Beta Amyloid Blog
Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci U S A. 2002 May 28;99(11):7705-10.
Tajima H, Niikura T, Hashimoto Y, Ito Y, Kita Y, Terashita K, Yamazaki K, Koto A, Aiso S, Nishimoto I. Evidence for in vivo production of Humanin peptide, a neuroprotective factor against Alzheimer's disease-related insults. Neurosci Lett. 2002 May 24;324(3):227-31.
Mitrasinovic OM, Murphy GM. Accelerated phagocytosis of amyloid-beta by mouse and human microglia overexpressing the M-CSF receptor. J Biol Chem. 2002 May 24;
Kinoshita A, Whelan CM, Berezovska O, Hyman BT. The gamma secretase-generated carboxyl terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J Biol Chem. 2002 May 24;
Choi J, Malakowsky CA, Talent JM, Conrad CC, Gracy RW. Identification of oxidized plasma proteins in Alzheimer's disease. Biochem Biophys Res Commun. 2002 May 24;293(5):1566-70. ,
Eto K, Asada T, Arima K, Makifuchi T, Kimura H. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun. 2002 May 24;293(5):1485-8.
Beeber C, Kieras FJ. Characterization of the chondroitin sulfates in wild type Caenorhabditis elegans. Biochem Biophys Res Commun. 2002 May 24;293(5):1374-6.
Leem JY, Vijayan S, Han P, Cai D, Machura M, Lopes KO, Veselits ML, Xu H, Thinakaran G. Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J Biol Chem. 2002 May 24;277(21):19236-40.
Tjernberg LO, Tjernberg A, Bark N, Shi Y, Ruzsicska BP, Bu Z, Thyberg J, Callaway DJ. Assembling amyloid fibrils from designed structures containing a significant amyloid beta-peptide fragment. Biochem J. 2002 May 22;Pt
DeTure MA, Di Noto L, Purich DL. In vitro assembly of Alzheimer-like filaments: How A small cluster of charged residues in Tau and MAP2 controls filament morphology. J Biol Chem. 2002 May 21;
Palotás A, Kálmán J, Laskay G, Juhász A, Janka Z, Penke B. [In Process Citation] Ideggyogy Sz. 2002 May 20;55(5-6):164-7.
Lleó A, Blesa R, Gendre J, Castellví M, Molinuevo JL, Oliva R. [Clinical characteristics of a family with early-onset Alzheimer's disease associated with a presenilin 1 mutation (M139T)] Med Clin (Barc). 2002 May 18;118(18):698-700.
Blanchard BJ, Stockwell BR, Ingram VM. Eliminating membrane depolarization caused by the Alzheimer peptide Abeta(1-42, aggr.). Biochem Biophys Res Commun. 2002 May 17;293(4):1204-8.
Bentley NM, LaDu MJ, Rajan C, Getz GS, Reardon CA. Apoprotein E Structural Requirements for SDS-stable complex formation with beta-amyloid(1-40). The Role of Salt Bridges. Biochem J. 2002 May 17;Pt
Green EK, Thaker U, McDonagh AM, Iwatsubo T, Lambert JC, Chartier-Harlin MC, Harris JM, Pickering-Brown SM, Lendon CL, Mann DM. A polymorphism within intron 11 of the tau gene is not increased in frequency in patients with sporadic Alzheimer's disease, nor does it influence the extent of tau pathology in the brain. Neurosci Lett. 2002 May 17;324(2):113-6.
Wei W, Wang X, Kusiak JW. Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection. J Biol Chem. 2002 May 17;277(20):17649-56.
Blanchard BJ, Thomas VL, Ingram VM. Mechanism of membrane depolarization caused by the Alzheimer Abeta1-42 peptide. Biochem Biophys Res Commun. 2002 May 17;293(4):1197-203.
Fuchsberger T, Padberg F, Faltraco F, Möller HJ, Hampel H. [Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer] MMW Fortschr Med. 2002 May 16;144(20):36-9.
Pepys MB, Herbert J, Hutchinson WL, Tennent GA, Lachmann HJ, Gallimore JR, Lovat LB, Bartfai T, Alanine A, Hertel C, Hoffmann T, Jakob-Roetne R, Norcross RD, Kemp JA, Yamamura K, Suzuki M, Taylor GW, Murray S, Thompson D, Purvis A, Kolstoe S, Wood SP, Hawkins PN. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature. 2002 May 16;417(6886):254-9.
Jackson GR, Wiedau-Pazos M, Sang TK, Wagle N, Brown CA
Ebinu JO, Yankner BA. A RIP Tide in Neuronal Signal Transduction. Neuron. 2002 May 16;34(4):499-502.
Gomis-Ruth FX, Bayes A, Sotiropoulou G, Pampalakis G, Tsetsenis T, Villegas V, Aviles FX, Coll M. The structure of human kallikrein 6 reveals a novel activation mechanism for the kallikrein family. J Biol Chem. 2002 May 16;
Olson JM, Goddard KA, Dudek DM. A Second Locus for Very-Late-Onset Alzheimer Disease: A Genome Scan Reveals Linkage to 20p and Epistasis between 20p and the Amyloid Precursor Protein Region. Am J Hum Genet. 2002 May 15;71(1)
Ahmed N, Argirov OK, Minhas HS, Cordeiro CA
Koeppen AH. Alzheimer's disease and related disorders annual. By Gauthier, S. and Cummings, J.L., ISBN 1-85317-909-4, Dunitz, London
Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci. 2002 May 15;22(10):RC221.
Roncarati R, Sestan N, Scheinfeld MH, Berechid BE, Lopez PA, Meucci O, McGlade JC, Rakic P, D'Adamio L. The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc Natl Acad Sci U S A. 2002 May 14;99(10):7102-7.
Conrad C, Vianna C, Freeman M, Davies P. A polymorphic gene nested within an intron of the tau gene: Implications for Alzheimer's disease. Proc Natl Acad Sci U S A. 2002 May 14;
McCaddon A, Regland B, Hudson P, Davies G. Functional vitamin B(12) deficiency and Alzheimer disease. Neurology. 2002 May 14;58(9):1395-9.
Palumaa P, Eriste E, Njunkova O, Pokras L, Jörnvall H, Sillard R. Brain-specific metallothionein-3 has higher metal-binding capacity than ubiquitous metallothioneins and binds metals noncooperatively. Biochemistry. 2002 May 14;41(19):6158-63.
Nichols MR, Moss MA, Reed DK, Lin WL, Mukhopadhyay R, Hoh JH, Rosenberry TL. Growth of beta-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry. 2002 May 14;41(19):6115-27.
Pomara N, Doraiswamy PM, Tun H, Ferris S. Mifepristone (RU 486) for Alzheimer's disease. Neurology. 2002 May 14;58(9):1436.
Gurwitz D, Chapman J, Weizman A. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology. 2002 May 14;58(9):1440.
Tarr PE, Roncarati R, Pelicci G, Pelicci PG, D'Adamio L. Tyrosine phosphorylation of the Beta -amyloid precursor protein cytoplasmic tail promotes interaction with shc. J Biol Chem. 2002 May 10;277(19):16798-804.
Schönknecht P, Lütjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, Beyreuther K, Schröder J. Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett. 2002 May 10;324(1):83-5. ,
Götz ME, Wacker M, Luckhaus C, Wanek P, Tatschner T, Jellinger K, Leblhuber F, Ransmayr G, Riederer P, Eder E. Unaltered brain levels of 1,N(2)-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease. Neurosci Lett. 2002 May 10;324(1):49-52.
Hernández F, Pérez M, Lucas JJ, Avila J. Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs. Brain Res. 2002 May 10;935(1-2):65-72.
Vafai SB, Stock JB. Protein phosphatase 2A methylation: a link between elevated plasma homocysteine and Alzheimer's Disease. FEBS Lett. 2002 May 8;518(1-3):1-4.
Cummings JL, Cole G. Alzheimer disease. JAMA. 2002 May 8;287(18):2335-8.
Buss S, Müller-Thomsen T, Hock C, Alberici A, Binetti G, Nitsch RM, Gal A, Finckh U. No association between DCP1 genotype and late-onset Alzheimer disease. Am J Med Genet. 2002 May 8;114(4):440-5. ,
Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H. Effect of IL-6 polymorphism on risk of Alzheimer disease: Genotype-phenotype association study in Japanese cases. Am J Med Genet. 2002 May 8;114(4):436-9. , ,
Stanyer L, Betteridge DJ, Smith CC. An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesis. FEBS Lett. 2002 May 8;518(1-3):72-8.
Tang G, Xie H, Xu L, Hao Y, Lin D, Ren D. Genetic study of apolipoprotein E gene, alpha-1 antichymotrypsin gene in sporadic Parkinson disease. Am J Med Genet. 2002 May 8;114(4):446-9.
Evin G, Smith MJ, Tziotis A, McLean C, Canterford L, Sharples RA, Cappai R, Weidemann A, Beyreuther K, Cotton RG, Masters CL, Culvenor JG. Alternative transcripts of presenilin-1 associated with frontotemporal dementia. Neuroreport. 2002 May 7;13(6):917-21.
Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S. Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport. 2002 May 7;13(6):903-7.
Sharpe MA, Ollosson R, Stewart VC, Clark JB. Oxidation of nitric oxide by oxo-manganese salen complexes:- a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem J. 2002 May 7;Pt
Ljungberg MC, Dayanandan R, Asuni A, Rupniak TH, Anderton BH, Lovestone S. Truncated apoE forms tangle-like structures in a neuronal cell line. Neuroreport. 2002 May 7;13(6):867-70.
Bian F, Nath R, Sobocinski G, Booher RN, Lipinski WJ, Callahan MJ, Pack A, Wang KK, Walker LC. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice. J Comp Neurol. 2002 May 6;446(3):257-66.
Ihl R. [Dementing disorders. What benefits do the new anti-dementia drugs have?] MMW Fortschr Med. 2002 May 6;Suppl 2:24-6, 28-9.
Sickmann A, Dormeyer W, Wortelkamp S, Woitalla D, Kuhn W, Meyer HE. Towards a high resolution separation of human cerebrospinal fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 May 5;771(1-2):167-196.
Skoog I. Magnetic-resonance imaging to assess Alzheimer's disease. Lancet. 2002 May 4;359(9317):1538-9.
Fischer H, Koenig U, Eckhart L, Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun. 2002 May 3;293(2):722-6.
Huse JT, Liu K, Pijak DS, Carlin D, Lee VM, Doms RW. Beta -secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J Biol Chem. 2002 May 3;277(18):16278-84.
Kienlen-Campard P, Miolet S, Tasiaux B, Octave JN. Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J Biol Chem. 2002 May 3;277(18):15666-70.
Albers DS, Beal MF. Mitochondrial dysfunction in progressive supranuclear palsy. Neurochem Int. 2002 May;40(6):559-64.
Dewachter I, Reversé D, Caluwaerts N, Ris L, Kuipéri C, Van den Haute C, Spittaels K, Umans L, Serneels L, Thiry E, Moechars D, Mercken M, Godaux E, Van Leuven F. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci. 2002 May 1;22(9):3445-53.
Savage MJ, Lin YG, Ciallella JR, Flood DG, Scott RW. Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition. J Neurosci. 2002 May 1;22(9):3376-85.
Forman MS, Schmidt ML, Kasturi S, Perl DP, Lee VM, Trojanowski JQ. Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol. 2002 May;160(5):1725-31.
Guénette SY. A role for APP in motility and transcription? Trends Pharmacol Sci. 2002 May;23(5):203-5.
Abbas N, Bednar I, Mix E, Marie S, Paterson D, Ljungberg A, Morris C, Winblad B, Nordberg A, Zhu J. Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J Neuroimmunol. 2002 May;126(1-2):50-7.
Block W, Jessen F, Träber F, Flacke S, Manka C, Lamerichs R, Keller E, Heun R, Schild H. Regional N-acetylaspartate reduction in the hippocampus detected with fast proton magnetic resonance spectroscopic imaging in patients with Alzheimer disease. Arch Neurol. 2002 May;59(5):828-34.
Mecocci P, Polidori MC, Cherubini A, Ingegni T, Mattioli P, Catani M, Rinaldi P, Cecchetti R, Stahl W, Senin U, Beal MF. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch Neurol. 2002 May;59(5):794-8. ,
Hogervorst E, Ribeiro HM, Molyneux A, Budge M, Smith AD. Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol. 2002 May;59(5):787-93. ,
Green A. Biochemical investigations in patients with dementia. Ann Clin Biochem. 2002 May;39(Pt 3):211-20.
Whyte EM, Mulsant BH, Butters MA, Qayyum M, Towers A, Sweet RA, Klunk W, Wisniewski S, DeKosky ST. Cognitive and behavioral correlates of low vitamin b(12) levels in elderly patients with progressive dementia. Am J Geriatr Psychiatry. 2002 May-Jun;10(3):321-7.
Bullock R. Increased risk of Alzheimer's disease in mothers who gave birth to children with Down's syndrome before 35 years of age. Evid Based Ment Health. 2002 May;5(2):61.
Damadzic R, Shuangshoti S, Giblen G, Herman MM. Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression. Acta Neuropathol (Berl). 2002 May;103(5):488-94.
Dhenain M, Privat N, Duyckaerts C, Jacobs RE. Senile plaques do not induce susceptibility effects in T2*-weighted MR microscopic images. NMR Biomed. 2002 May;15(3):197-203.
Ballard C, O'Brien J, Tovee M. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002 May;72(5):565-6.
Colloby SJ, Fenwick JD, Williams ED, Paling SM, Lobotesis K, Ballard C, McKeith I, O'Brien JT. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med. 2002 May;29(5):615-22.
Sun MK, Alkon DL. Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25-35). J Neurophysiol. 2002 May;87(5):2441-9.
Leslie RA. Imaging Alzheimer's disease in vivo: not so 'implaque-able' anymore. Trends Neurosci. 2002 May;25(5):232-3.
Xie Z, Wei M, Morgan TE, Fabrizio P, Han D, Finch CE, Longo VD. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J Neurosci. 2002 May 1;22(9):3484-92.
Ravikumar B, Duden R, Rubinsztein DC. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet. 2002 May 1;11(9):1107-17.
Ponting CP, Hutton M, Nyborg A, Baker M, Jansen K, Golde TE. Identification of a novel family of presenilin homologues. Hum Mol Genet. 2002 May 1;11(9):1037-44.
Beal MF. Oxidatively modified proteins in aging and disease(1,2). Free Radic Biol Med. 2002 May 1;32(9):797-803.
Parmar P, Limson J, Nyokong T, Daya S. Melatonin protects against copper-mediated free radical damage. J Pineal Res. 2002 May;32(4):237-42.
Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. Am J Psychiatry. 2002 May;159(5):738-45.
Martin JB. The integration of neurology, psychiatry, and neuroscience in the 21st century. Am J Psychiatry. 2002 May;159(5):695-704.
Doubleday EK, Snowden JS, Varma AR, Neary D. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002 May;72(5):602-7.
Bucks RS, Byrne L, Haworth J, Wilcock G, Hyde J, Emmerson C, Spaull D. Interventions in Alzheimer's disease. Int J Geriatr Psychiatry. 2002 May;17(5):492-3.
Heinik J, Solomesh I, Shein V, Becker D. Clock drawing test in mild and moderate dementia of the Alzheimer's type: a comparative and correlation study. Int J Geriatr Psychiatry. 2002 May;17(5):480-5.
Evers MM, Samuels SC, Lantz M, Khan K, Brickman AM, Marin DB. The prevalence, diagnosis and treatment of depression in dementia patients in chronic care facilities in the last six months of life. Int J Geriatr Psychiatry. 2002 May;17(5):464-72.
Andrieu S, Reynish E, Nourhashemi F, Shakespeare A, Moulias S, Ousset PJ, Sagnier P, Richard A, Albarede JL, Vellas B. Predictive factors of acute hospitalization in 134 patients with Alzheimer's disease: a one year prospective study. Int J Geriatr Psychiatry. 2002 May;17(5):422-6.
Schnaider Beeri M, Werner P, Davidson M, Noy S. The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry. 2002 May;17(5):403-8.
Murman DL, Chen Q, Colucci PM, Colenda CC, Gelb DJ, Liang J. Comparison of healthcare utilization and direct costs in three degenerative dementias. Am J Geriatr Psychiatry. 2002 May-Jun;10(3):328-36.
Smith MA, Drew KL, Nunomura A, Takeda A, Hirai K, Zhu X, Atwood CS, Raina AK, Rottkamp CA, Sayre LM, Friedland RP, Perry G. Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs? Neurochem Int. 2002 May;40(6):527-31.
Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, Hauw JJ. Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (Berl). 2002 May;103(5):481-7.
Xiang Z, Ho L, Valdellon J, Borchelt D, Kelley K, Spielman L, Aisen PS, Pasinetti GM. Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's disease neuropathology. Neurobiol Aging. 2002 May-Jun;23(3):327-34.
Monro OR, Mackic JB, Yamada S, Segal MB, Ghiso J, Maurer C, Calero M, Frangione B, Zlokovic BV. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol Aging. 2002 May-Jun;23(3):405-12.
Selley ML, Close DR, Stern SE. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):383-8. ,
Wang X, DeKosky ST, Ikonomovic MD, Kamboh MI. Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls. Neurobiol Aging. 2002 May-Jun;23(3):377-82. ,
Vincent VA, Selwood SP, Murphy GM. Proinflammatory effects of M-CSF and A beta in hippocampal organotypic cultures. Neurobiol Aging. 2002 May-Jun;23(3):349-62.
Masera RG, Prolo P, Sartori ML, Staurenghi A, Griot G, Ravizza L, Dovio A, Chiappelli F, Angeli A. Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease. Psychoneuroendocrinology. 2002 May;27(4):447-61.
Martindale D. Peeling plaque. Researchers remain optimistic about a vaccine against Alzheimer's. Sci Am. 2002 May;286(5):18, 20.
Mannens GS, Snel CA, Hendrickx J, Verhaeghe T, Le Jeune L, Bode W, van Beijsterveldt L, Lavrijsen K, Leempoels J, Van Osselaer N, Van Peer A, Meuldermans W. The metabolism and excretion of galantamine in rats, dogs, and humans. Drug Metab Dispos. 2002 May 1;30(5):553-63.
Bosetti F, Brizzi F, Barogi S, Mancuso M, Siciliano G, Tendi EA, Murri L, Rapoport SI, Solaini G. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):371-6.
Beloosesky Y, Salman H, Bergman M, Bessler H, Djaldetti M. Cytokine levels and phagocytic activity in patients with Alzheimer's disease. Gerontology. 2002 May-Jun;48(3):128-32.
Morris HR, Gibb G, Katzenschlager R, Wood NW, Hanger DP, Strand C, Lashley T, Daniel SE, Lees AJ, Anderton BH, Revesz T. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain. 2002 May;125(Pt 5):969-75.
Santos MD, Alkondon M, Pereira EF, Aracava Y, Eisenberg HM, Maelicke A, Albuquerque EX. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol Pharmacol. 2002 May;61(5):1222-34.
Desgranges B, Baron JC, Lalevée C, Giffard B, Viader F, de la Sayette V, Eustache F. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain. 2002 May;125(Pt 5):1116-24.
Schiffman SS, Graham BG, Sattely-Miller EA, Zervakis J, Welsh-Bohmer K. Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's disease. Neurobiol Aging. 2002 May-Jun;23(3):397-404.
Atack JR, Schapiro MB. Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF. Neurobiol Aging. 2002 May-Jun;23(3):389-96.
Shoji M, Matsubara E, Murakami T, Manabe Y, Abe K, Kanai M, Ikeda M, Tomidokoro Y, Shizuka M, Watanabe M, Amari M, Ishiguro K, Kawarabayashi T, Harigaya Y, Okamoto K, Nishimura T, Nakamura Y, Takeda M, Urakami K, Adachi Y, Nakashima K, Arai H, Sasaki H, Kanemaru K, Yamanouchi H, Yoshida Y, Ichise K, Tanaka K, Hamamoto M, Yamamoto H, Matsubayashi T, Yoshida H, Toji H, Nakamura S, Hirai S. Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group. Neurobiol Aging. 2002 May-Jun;23(3):363-70. ,
Vogelgesang S, Schroeder E, Walker LC, Pahnke J, Naubereit A, Walther R, Stausske D, Warzok RW. Activated microglia do not mediate the early deposition of Abeta in carriers of the apolipoprotein Eepsilon4 allele. Clin Neuropathol. 2002 May-Jun;21(3):99-106.
Tozaki H, Matsumoto A, Kanno T, Nagai K, Nagata T, Yamamoto S, Nishizaki T. The inhibitory and facilitatory actions of amyloid-beta peptides on nicotinic ACh receptors and AMPA receptors. Biochem Biophys Res Commun. 2002 May 31;294(1):42-5.
Fromage B, Anglade P. [The aging of Down's Syndrome subjects] Encephale. 2002 May-Jun;28(3):212-6.
Crespi F. Nefiracetam. Daiichi Seiyaku. Curr Opin Investig Drugs. 2002 May;3(5):788-93.
Walker LC, LeVine H. Proteopathy: the next therapeutic frontier? Curr Opin Investig Drugs. 2002 May;3(5):782-7.
LeBlanc A. Estrogen and Alzheimer's disease. Curr Opin Investig Drugs. 2002 May;3(5):768-73.
Elyaman W, Yardin C, Hugon J. Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly. J Neurochem. 2002 May;81(4):870-80.
Jacob B, Hache JC, Pasquier F. [Dysfunction of the magnocellular pathway in Alzheimer's disease] Rev Neurol (Paris). 2002 May;158(5 Pt 1):555-64.
Fukami S, Watanabe K, Iwata N, Haraoka J, Lu B, Gerard NP, Gerard C, Fraser P, Westaway D, George-Hyslop PS, Saido TC. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology. Neurosci Res. 2002 May;43(1):39-56.
Zarghooni M, Soosaipillai A, Grass L, Scorilas A, Mirazimi N, Diamandis EP. Decreased concentration of human kallikrein 6 in brain extracts of Alzheimer's disease patients. Clin Biochem. 2002 May;35(3):225-231. ,
Nassar BA, Darvesh S, Bevin LD, Rockwood K, Kirkland SA, O'Neill BJ, Bata IR, Johnstone DE, Title LM. Relation between butyrylcholinesterase K variant, paraoxonase 1 (PON1) Q and R and apolipoprotein E epsilon4 genes in early-onset coronary artery disease. Clin Biochem. 2002 May;35(3):205-9.
Abe T, Tohgi H. [Free radical in Alzheimer's disease] Nippon Ronen Igakkai Zasshi. 2002 May;39(3):268-70.
Burgaud JL, Ongini E, Del Soldato P. Nitric oxide-releasing drugs: a novel class of effective and safe therapeutic agents. Ann N Y Acad Sci. 2002 May;962:360-71.
Gertz HJ, Wolf H, Arendt T. [In Process Citation] Nervenarzt. 2002 May;73(5):393-404.
Lau KF, Howlett DR, Kesavapany S, Standen CL, Dingwall C, McLoughlin DM, Miller CC. Cyclin-Dependent Kinase-5/p35 Phosphorylates Presenilin 1 to Regulate Carboxy-Terminal Fragment Stability. Mol Cell Neurosci. 2002 May;20(1):13-20.
Storey E, Slavin MJ, Kinsella GJ. Patterns of cognitive impairment in Alzheimer's disease: assessment and differential diagnosis. Front Biosci. 2002 May 1;7:E155-84.
Chen QS, Wei WZ, Shimahara T, Xie CW. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem. 2002 May;77(3):354-71.
Schildein S, Huston JP, Schwarting RK. Open field habituation learning is improved by nicotine and attenuated by mecamylamine administered posttrial into the nucleus accumbens. Neurobiol Learn Mem. 2002 May;77(3):277-90.
Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Di Simplicio P, Colombo R, Milzani A. Methionine oxidation as a major cause of the functional impairment of oxidized actin. Free Radic Biol Med. 2002 May 1;32(9):927-37.
Tsolaki M, Iakovidou V, Papadopoulou E, Aminta M, Nakopoulou E, Pantazi T, Kazis A. Greek validation of the seven-minute screening battery for Alzheimer's disease in the elderly. Am J Alzheimers Dis Other Demen. 2002 May-Jun;17(3):139-48.
Drachman DA. The treatment of Alzheimer's disease: where have we been, and where are we going? Am J Alzheimers Dis Other Demen. 2002 May-Jun;17(3):133-4.
Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS. Role of nitric oxide in inflammation-mediated neurodegeneration. Ann N Y Acad Sci. 2002 May;962:318-31.
Colton CA, Brown CM, Czapiga M, Vitek MP. Apolipoprotein-E allele-specific regulation of nitric oxide production. Ann N Y Acad Sci. 2002 May;962:212-25.
Frölich L, Hoyer S. [In Process Citation] Nervenarzt. 2002 May;73(5):422-7.
Sugimoto H, Ogura H, Arai Y, Limura Y, Yamanishi Y. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor. Jpn J Pharmacol. 2002 May;89(1):7-20.
Varma AR, Laitt R, Lloyd JJ, Carson KJ, Snowden JS, Neary D, Jackson A. Diagnostic value of high signal abnormalities on T2 weighted MRI in the differentiation of Alzheimer's, frontotemporal and vascular dementias. Acta Neurol Scand. 2002 May;105(5):355-64.
Calderón-Garcidueñas L, Azzarelli B, Acuna H, Garcia R, Gambling TM, Osnaya N, Monroy S, DEL Tizapantzi MR, Carson JL, Villarreal-Calderon A, Rewcastle B. Air pollution and brain damage. Toxicol Pathol. 2002 May-Jun;30(3):373-89.
Silver MH, Newell K, Brady C, Hedley-White ET, Perls TT. Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians. Psychosom Med. 2002 May-Jun;64(3):493-501.
Nordberg A, Hellström-Lindahl E, Lee M, Johnson M, Mousavi M, Hall R, Perry E, Bednar I, Court J. Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J Neurochem. 2002 May;81(3):655-8.
Fodero LR, Sáez-Valero J, McLean CA, Martins RN, Beyreuther K, Masters CL, Robertson TA, Small DH. Altered glycosylation of acetylcholinesterase in APP (SW) Tg2576 transgenic mice occurs prior to amyloid plaque deposition. J Neurochem. 2002 May;81(3):441-8.
Ragnarsson L, Mortensen M, Dodd PR, Lewis RJ. Spermine modulation of the glutamate(NMDA) receptor is differentially responsive to conantokins in normal and Alzheimer's disease human cerebral cortex. J Neurochem. 2002 May;81(4):765-79.
Festoff BW, SantaCruz K, Arnold PM, Sebastian CT, Davies PJ, Citron BA. Injury-induced "switch" from GTP-regulated to novel GTP-independent isoform of tissue transglutaminase in the rat spinal cord. J Neurochem. 2002 May;81(4):708-18.
LaFontaine MA, Mattson MP, Butterfield DA. Oxidative stress in synaptosomal proteins from mutant presenilin-1 knock-in mice: implications for familial Alzheimer's disease. Neurochem Res. 2002 May;27(5):417-21.
Rüb U, Del Tredici K, Del Turco D, Braak H. The intralaminar nuclei assigned to the medial pain system and other components of this system are early and progressively affected by the Alzheimer's disease-related cytoskeletal pathology. J Chem Neuroanat. 2002 May;23(4):279-90.
Kasparová J, Dolezal V. [In Process Citation] Cesk Fysiol. 2002 May;51(2):82-94.
Grammas P, Ovase R. Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain. Am J Pathol. 2002 May;160(5):1583-7.
Zanetti O, Oriani M, Geroldi C, Binetti G, Frisoni GB, Di Giovanni G, De Vreese LP. Predictors of cognitive improvement after reality orientation in Alzheimer's disease. Age Ageing. 2002 May;31(3):193-6.
Kanski J, Aksenova M, Stoyanova A, Butterfield DA. Ferulic acid antioxidant protection against hydroxyl and peroxyl radical oxidation in synaptosomal and neuronal cell culture systems in vitro: structure-activity studies. J Nutr Biochem. 2002 May;13(5):273-281.
Fiala M, Liu QN, Sayre J, Pop V, Brahmandam V, Graves MC, Vinters HV. Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer's disease brain and damage the blood-brain barrier. Eur J Clin Invest. 2002 May;32(5):360-71.
Callahan LM, Vaules WA, Coleman PD. Progressive reduction of synaptophysin message in single neurons in Alzheimer disease. J Neuropathol Exp Neurol. 2002 May 1;61(5):384-95. ,
Dominici R, Cattaneo M, Malferrari G, Archi D, Mariani C, Grimaldi E, Biunno I. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1alpha. Immunogenetics. 2002 May;54(2):82-6.
Sun A, Koelsch G, Tang J, Bing G. Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls. Exp Neurol. 2002 May;175(1):10-22.
Morganroth J, Graham S, Hartman R, Anand R. Electrocardiographic effects of rivastigmine. J Clin Pharmacol. 2002 May;42(5):558-68.
Grossman M. Frontotemporal dementia: a review. J Int Neuropsychol Soc. 2002 May;8(4):566-83.
Miller JW. Vitamin B12 deficiency, tumor necrosis factor-alpha, and epidermal growth factor: a novel function for vitamin B12? Nutr Rev. 2002 May;60(5 Pt 1):142-4.
Murray KN, Abeles N. Nicotine's effect on neural and cognitive functioning in an aging population. Aging Ment Health. 2002 May;6(2):129-38.
Wiltfang J, Esselmann H, Bibl M, Smirnov A, Otto M, Paul S, Schmidt B, Klafki HW, Maler M, Dyrks T, Bienert M, Beyermann M, Rüther E, Kornhuber J. Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem. 2002 May;81(3):481-96. ,
Ono K, Hasegawa K, Yoshiike Y, Takashima A, Yamada M, Naiki H. Nordihydroguaiaretic acid potently breaks down pre-formed Alzheimer's beta-amyloid fibrils in vitro. J Neurochem. 2002 May;81(3):434-40.
Sergeant N, David JP, Champain D, Ghestem A, Wattez A, Delacourte A. Progressive decrease of amyloid precursor protein carboxy terminal fragments (APP-CTFs), associated with tau pathology stages, in Alzheimer's disease. J Neurochem. 2002 May;81(4):663-72.
Riemenschneider M. Abeta42 plasma in the diagnosis of Alzheimer's disease. Eur Psychiatry. 2002 May;17 Suppl 1:77.
Pelgrim-Korf ES, Scheltens PH. Hippocampal atrophy on MRI in the diagnosis of Alzheimer's disease. Eur Psychiatry. 2002 May;17 Suppl 1:76.
Kilpatrick GJ, Tilbrook GS. Memantine. Merz. Curr Opin Investig Drugs. 2002 May;3(5):798-806.
Nyberg-Swenson BE. Are acetylcholine-induced acetyl groups driving fuel cells in the systems of transducin, t and G proteins? Med Hypotheses. 2002 May;58(5):388-94.
Hetényi C, Körtvélyesi T, Penke B. Mapping of possible binding sequences of two Beta-sheet breaker peptides on Beta amyloid Peptide of Alzheimer's disease. Bioorg Med Chem. 2002 May;10(5):1587-93.
Engeland C, Mahoney C, Mohr E, Ilivitsky V, Knott VJ. Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease. An event-related potential study. Pharmacol Biochem Behav. 2002 May;72(1-2):457-64.
Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol. 2002 May;34(5):427-31.
Sinigaglia-Coimbra R, Cavalheiro A, Coimbra G. Postischemic hyperthermia induces Alzheimer-like pathology in the rat brain. Acta Neuropathol (Berl). 2002 May;103(5):444-52.
Ohm G, Münch S, Schönheit B, Zarski R, Nitsch R. Transneuronally altered dendritic processing of tangle-free neurons in Alzheimer's disease. Acta Neuropathol (Berl). 2002 May;103(5):437-43.
Dodart JC, Bales KR, Gannon KS, Greene SJ, Demattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM, Paul SM. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci. 2002 May;5(5):452-7.
Foldi NS, Lobosco JJ, Schaefer LA. The effect of attentional dysfunction in Alzheimer's disease: theoretical and practical implications. Semin Speech Lang. 2002 May;23(2):139-50.
Grundman M, Grundman M, Delaney P. Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc. 2002 May;61(2):191-202.
Meydani M, Meydani M. Nutrition interventions in aging and age-associated disease. Proc Nutr Soc. 2002 May;61(2):165-71.
Filippini G. [Preventing Alzheimer's disease through a change in diet: a feasible research] Epidemiol Prev. 2002 May-Jun;26(3):106.
Ignjatovic D, Ignjatovic M. Alzheimer's disease diagnostics and the treatment at the psychiatric out-patients department. Eur Psychiatry. 2002 May;17 Suppl 1:130-1.
Hampel H, Bürger K, Zinkowski R, Teipel SJ, Kohnken R, Kerkman D, DeBernardis J, Kahle P, Rapoport SI, Sunderland T, Arai H, Tapiola T, Hoffmann-Kiefer K, Andreasen N, Blennow K, Möller HJ, Davies P. CSF tau phosphorylated at threonine 231, total tau and neuronal thread protein in the diagnosis of Alzheimer's disease. Eur Psychiatry. 2002 May;17 Suppl 1:77.
Ballard C, Johnson M, Piggott M, Perry R, O'Brien J, Rowan E, Perry E, Lantos P, Cairns N, Holmes C. A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. J Affect Disord. 2002 May;69(1-3):219-23.
Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study. Ann Neurol. 2002 May;51(5):567-77.
Teter B, Xu PT, Gilbert JR, Roses AD, Galasko D, Cole GM. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J Neurosci Res. 2002 May 1;68(3):331-6.
Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. J Neural Transm. 2002 May;109(5-6):837-55.
Morris MS. Folate, homocysteine, and neurological function. Nutr Clin Care. 2002 May-Jun;5(3):124-32.
Cho MJ, Lyoo IK, Lee DW, Kwon JS, Lee JS, Lee DS, Jung JK, Lee MC. Brain single photon emission computed tomography findings in depressive pseudodementia patients. J Affect Disord. 2002 May;69(1-3):159-66.
Casolini P, Catalani A, Zuena AR, Angelucci L. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res. 2002 May 1;68(3):337-43.
Freo U, Pizzolato G, Dam M, Ori C, Battistin L. A short review of cognitive and functional neuroimaging studies of cholinergic drugs: implications for therapeutic potentials. J Neural Transm. 2002 May;109(5-6):857-70.
Sofic E, Rustembegovic A, Kroyer G, Cao G. Serum antioxidant capacity in neurological, psychiatric, renal diseases and cardiomyopathy. J Neural Transm. 2002 May;109(5-6):711-9.
Lallement G, Baille V, Baubichon D, Carpentier P, Collombet JM, Filliat P, Foquin A, Four E, Masqueliez C, Testylier G, Tonduli L, Dorandeu F. Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology. 2002 May;23(1):1-5.
Sinha S. The role of beta-amyloid in Alzheimer's disease. Med Clin North Am. 2002 May;86(3):629-39.
Trojanowski JQ, Lee VM. The role of tau in Alzheimer's disease. Med Clin North Am. 2002 May;86(3):615-27.
Doraiswamy PM, Krishnan KR, Anand R, Sohn H, Danyluk J, Hartman RD, Veach J. Long-term effects of rivastigmine in moderately severe Alzheimer's disease: does early initiation of therapy offer sustained benefits? Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):705-12.
Jackson GR, Wiedau-Pazos , Sang , Wagle , Brown , Massachi , Geschwind . Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron. 2002 May;34(4):509-19. Abstract
Schönknecht P, Pantel J, Lütjohann D, Hartmann T, Beyreuther K, Schröder J. Cerebrospinal fluid 24S-hydroxycholesterol is increased in Alzheimer's disease compared to healthy controls. Eur Psychiatry. 2002 May;17 Suppl 1:131.
Schönknecht P, Pantel J, Essig M, Amann M, Schad L, Schröder J. Progression of hippocampal atrophy is associated with clinical deterioration in Alzheimer's disease. Eur Psychiatry. 2002 May;17 Suppl 1:110-1.
Blennow K. Tau, phospho-tau and Ab42 in cerebrospinal fluid in Alzheimer's disease. Eur Psychiatry. 2002 May;17 Suppl 1:77.
Iqbal K. Total-tau, Abeta(1-42) and Ubiquitin in CSF in the diagnosis of Alzheimer disease. Eur Psychiatry. 2002 May;17 Suppl 1:76.
Schönknecht P, Pantel J, Klinga C, Jensen M, Hartmann T, Beyreuther K, Schröder J. Cerebrospinal fluid estradiol and beta-amyloid levels in female patients with Alzheimer's disease. Eur Psychiatry. 2002 May;17 Suppl 1:41.
Jellinger KA. Alzheimer disease and cerebrovascular pathology: an update. J Neural Transm. 2002 May 1;109(5-6):813-36.
Sobow T, Kloszewska I. Blood pressure dysregulation and Alzheimer's disease: a case-control study. Eur Psychiatry. 2002 May;17 Suppl 1:132.
Potki SG, Anand R, Hartman R, Veach J, Grossberg G. Impact of Alzheimer's disease and rivastigmine treatment on activities of daily living over the course of mild to moderately severe disease. Prog Neuropsychopharmacol Biol Psychiatry. 2002 May;26(4):713-20.
Berrino F. [Western diet and Alzheimer's disease] Epidemiol Prev. 2002 May-Jun;26(3):107-15.
Domenici MR, Paradisi S, Sacchetti B, Gaudi S, Balduzzi M, Bernardo A, Ajmone-Cat MA, Minghetti L, Malchiodi-Albedi F. The presence of astrocytes enhances beta amyloid-induced neurotoxicity in hippocampal cell cultures. J Physiol Paris. 2002 May-Aug;96(3-4):313-6.
No comments:
Post a Comment